IN8BIO, Inc.
NASDAQ:INAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IN8BIO, Inc.
NASDAQ:INAB
|
US |
|
MAG Silver Corp
TSX:MAG
|
CA |
|
Ecovyst Inc
NYSE:ECVT
|
US |
|
Discover Financial Services
NYSE:DFS
|
US |
|
Premium Group Co Ltd
TSE:7199
|
JP |
|
Brixmor Property Group Inc
NYSE:BRX
|
US |
|
Singapore Telecommunications Ltd
SGX:Z74
|
SG |
|
Fleetpartners Group Ltd
ASX:FPR
|
AU |
|
CRE Logistics REIT Inc
TSE:3487
|
JP |
|
Panthera Resources PLC
LSE:PAT
|
UK |
|
Lipocine Inc
NASDAQ:LPCN
|
US |
|
Chefs' Warehouse Inc
NASDAQ:CHEF
|
US |
|
Buckle Inc
NYSE:BKE
|
US |
|
Molina Healthcare Inc
NYSE:MOH
|
US |
|
Unico Silver Ltd
ASX:USL
|
AU |
|
Betsson AB
STO:BETS B
|
SE |
|
Galapagos NV
AEX:GLPG
|
BE |
|
C
|
CAP SA
SGO:CAP
|
CL |
|
Dynatrace Inc
NYSE:DT
|
US |
Bankruptcy Probability
IN8BIO, Inc.'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IN8BIO, Inc. Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
I
|
IN8BIO, Inc.
NASDAQ:INAB
|
18.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IN8BIO, Inc.'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IN8BIO, Inc. has no debt.
You can find a full breakdown on its Balance Sheet.